Clinical thrombolysis in stroke

Thrombosis Research

Volumn 103, Issue SUPPL. 1, 2001, Pages

  Grond, M ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Strasse zu Kln   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN DERIVATIVE; PROUROKINASE; STREPTOKINASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; META ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DIAGNOSTIC IMAGING; HUMANS; THROMBOLYTIC THERAPY;

EID: 0035975609     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00310-3     Document Type: Article

References (36)

1. Thrombolysis with fibrinolysin in cerebral artery occlusion
2. Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA stroke trial
3. For the ECASS study group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
4. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous altephase in acute ischaemic stroke (ECASS II)
5. Recombinant tissue-type plasminogen activator (altephase) for ischemic stroke 3 to 5 hours after symptom onset The ATLANTIS study: A randomized controlled trial
6. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial
7. Trials of streptokinase in severe acute ischemic stroke
8. Randomized controlled trail of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke
9. Thrombolytic therapy with streptokinase in acute ischemic stroke
10. Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA stroke trial
11. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
12. Effects of tissue plasminogen activator for acute ischemic stroke at one year
13. Interobserver agreement for the assessment of handicap in stroke patients
14. Thrombolysis - Not a panacea for ischemic stroke
15. Intravenous tissue-type plasminogen activator for treatment of acute stroke The standard treatment with alteplase to reverse stroke (STARS) study
16. Use of tissue-type plasminogen activator for acute ischemic stroke. The Cleveland experience
17. Treating acute stroke patients with intravenous t-PA. The OSF stroke network experience
18. Intravenous tissue plasminogen activator for acute ischemic stroke. Feasibility, safety and efficacy in the first year of clinical practice
19. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke. Determination of etiological, topographic, and radiological outcome factors
20. One-year follow-up in acute stroke patients treated with rt-PA in clinical routine
21. A large multinational investigation to predict t-PA related symptomatic ICH in patients with acute ischemic stroke
22. The Canadian activase for stroke effectiveness study
23. European stroke initiative: Recommendations for stroke management. Organisation of stroke care
24. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association
25. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
26. Effect of training on the recognition of large ischemic lesions on CT scans obtained within 6 hours of stroke onset
27. Early computed-tomography abnormalities in acute stroke
28. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI
29. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging
30. In Time-II: More than a study on lanoteplase
31. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Management of Acute Myocardial Infarction)
32. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
33. Risk of early anticoagulation after thrombolysis
34. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke
35. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients
36. Urgent therapy for acute stroke. Effects of a stroke trial on untreated patients